These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7766779)

  • 1. Change points in the series of T4 counts prior to AIDS.
    Kiuchi AS; Hartigan JA; Holford TR; Rubinstein P; Stevens CE
    Biometrics; 1995 Mar; 51(1):236-48. PubMed ID: 7766779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease.
    Mcneil AJ; Gore SM
    Stat Med; 1996 Jan; 15(1):75-92. PubMed ID: 8614747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
    AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.
    Lyles CM; Dorrucci M; Vlahov D; Pezzotti P; Angarano G; Sinicco A; Alberici F; Alcorn TM; Vella S; Rezza G
    J Infect Dis; 1999 Oct; 180(4):1018-24. PubMed ID: 10479126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model-based approach to estimate the AIDS-free time distribution in homosexual men using longitudinal data.
    Dunlop DD; Tamhane AC; Chmiel JS; Phair JP
    J Biopharm Stat; 1994 Jul; 4(2):129-46. PubMed ID: 7951270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
    Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
    Goggins WB; Finkelstein DM; Schoenfeld DA; Zaslavsky AM
    Biometrics; 1998 Dec; 54(4):1498-507. PubMed ID: 9883548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flexible B-spline model for multiple longitudinal biomarkers and survival.
    Brown ER; Ibrahim JG; DeGruttola V
    Biometrics; 2005 Mar; 61(1):64-73. PubMed ID: 15737079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study.
    van Benthem BH; Veugelers PJ; Cornelisse PG; Strathdee SA; Kaldor JM; Shafer KA; Coutinho RA; van Griensven GJ
    AIDS; 1998 Jun; 12(9):1039-45. PubMed ID: 9662201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.
    Lyles RH; Muñoz A; Yamashita TE; Bazmi H; Detels R; Rinaldo CR; Margolick JB; Phair JP; Mellors JW
    J Infect Dis; 2000 Mar; 181(3):872-80. PubMed ID: 10720507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.
    Gupta P; Kingsley L; Armstrong J; Ding M; Cottrill M; Rinaldo C
    Virology; 1993 Oct; 196(2):586-95. PubMed ID: 8103948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.
    Begtrup K; Melbye M; Biggar RJ; Goedert JJ; Knudsen K; Andersen PK
    Am J Epidemiol; 1997 Apr; 145(7):629-35. PubMed ID: 9098180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical estimation of a distribution function with truncated and doubly interval-censored data and its application to AIDS studies.
    Sun J
    Biometrics; 1995 Sep; 51(3):1096-104. PubMed ID: 7548693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.